Investment Strategy How to Use Orange Book and Purple Book Data for Pharma IP Valuation For investors building positions in companies with significant biologic revenue exposure to loss of exclusivity, the Purple Book exclusivity expiration date is the starting point, not the end point of analysis
However, dual agonists consistently outperform them
Larger companies (5,000+ workers) are more likely to see a major cost impact
Soluble Vegetable Fiber (Maize), Proprietary Flatter Me Enzyme Blend: Protease 3.0, Protease 4.5, Protease 6.0, Peptidase, Bromelain, Neutral Bacterial Protease, Papain, Lipase, Amylase, Glucoamylase, Alpha-galactosidase, Invertase, Diastase, Hemicellulase, Cellulase AN, Beta-Glucanase, Phytase, Lactase, Herbal Blend: Ginger Root (Zingiber officinale), Fennel Seed (Foeniculum Vulgare), Peppermint Leaf (Mentha Piperita)
Our skilled medical team also includes a PA who specializes in weight loss, allowing our patients to always receive the highest caliber of guidance and care
